4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-031245
Principal Accounting Officer sold 5,947 shares at $22.50 ($133,808)
- Principal Accounting Officer acquired 11,894 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kihara James Principal Accounting Officer | 2023-05-17 | Option exercise | +5,947 | 11,144 | D | ||
| Kihara James Principal Accounting Officer | 2023-05-17 | Option exercise | +5,947 | 17,091 | D | ||
| Kihara James Principal Accounting Officer | 2023-05-17 | Sale | −5,947 | $22.50 | $133,808 | 11,144 | D |
| Derivatives | |||||||
| Kihara James Principal Accounting Officer | 2023-05-17 | Option exercise · Restricted Stock Units | −5,947 | 9,913 | D | ||
| Kihara James Principal Accounting Officer | 2023-05-17 | Option exercise · Restricted Stock Units | −5,947 | 9,913 | D | ||
| Open-market sales · 5,947 sh · avg $22.50 · $133,808 | |||||||
Loading xslF345X04/doc4.xml…